USANA Health Sciences
(NYSE) USNA
USANA Health Sciences Financials at a Glance
Market Cap
$320.78M
Revenue (TTM)
$925.26M
Net Income (TTM)
$10.76M
EPS (TTM)
$0.56
P/E Ratio
31.04
Dividend
$0.00
Beta (Volatility)
0.73 (Low)
Dividend
$0.00
Beta (Volatility)
0.73 (Low)
Price
$17.49
Volume
2,562
Open
$17.13
Price
$17.49
Volume
2,562
Open
$17.13
Previous Close
$17.49
Daily Range
$16.98 - $17.79
52-Week Range
$16.71 - $38.32
Dividend
$0.00
Beta (Volatility)
0.73 (Low)
Price
$17.49
Volume
2,562
Open
$17.13
Previous Close
$17.49
Daily Range
$16.98 - $17.79
52-Week Range
$16.71 - $38.32
USNA News
USNA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout USANA Health Sciences
Industry
Personal Products
Sector
Consumer StaplesEmployees
1,570
CEO
Jim H. Brown, MBA
Website
www.usana.comHeadquarters
Salt Lake City, UT 84120, US
USNA Financials
Key Financial Metrics (TTM)
Gross Margin
78%
Operating Margin
5%
Net Income Margin
1%
Return on Equity
2%
Return on Capital
8%
Return on Assets
1%
Earnings Yield
3.22%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$320.78M
Shares Outstanding
18.46M
Volume
2.56K
Short Interest
0.00%
Avg. Volume
130.31K
Financials (TTM)
Gross Profit
$724.40M
Operating Income
$50.86M
EBITDA
$90.56M
Operating Cash Flow
$22.35M
Capital Expenditure
$13.82M
Free Cash Flow
$8.53M
Cash & ST Invst.
$158.38M
Total Debt
$14.00M
USANA Health Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$226.20M
+5.9%
Gross Profit
$200.79M
+17.4%
Gross Margin
88.77%
N/A
Market Cap
$320.78M
N/A
Market Cap/Employee
$188.69K
N/A
Employees
1,700
N/A
Net Income
$1.77M
-139.6%
EBITDA
$27.54M
+67.5%
Quarterly Fundamentals
Net Cash
$144.38M
+1.3%
Accounts Receivable
$9.11M
+10.7%
Inventory
$102.61M
+47.1%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$14.00M
-51.7%
Return on Assets
1.45%
N/A
Return on Invested Capital
8.28%
N/A
Free Cash Flow
$6.18M
-255.3%
Operating Cash Flow
$3.39M
-158.6%